Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04105920 | Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies(HYALEREC) | active not recruiting | N/A | 162 | Hospices Civils de LyonOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06769425 | HS-10502 Combination Treatment in Patients With Advanced Solid Tumors(HS-10502) | recruiting | Phase 1 | 157 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 |
| Jun 24, 2025 |
| clinicaltrials |
| NCT05191680 | TherApeutics in Early ProState Cancer (TAPS02) | recruiting | Phase 2 | 90 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jun 20, 2025 | clinicaltrials |
| NCT06982469 | High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy | recruiting | — | 20 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT07015866 | Creative Arts Therapy on Body Image, Self-esteem, Anxiety and Depression in Post-Treatment Prostate Cancer Patients | not yet recruiting | N/A | 72 | The Hong Kong Polytechnic UniversityOTHER | 0 | Jun 18, 2025 | clinicaltrials |
| NCT06684652 | Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer | recruiting | N/A | 300 | Peking University First HospitalOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT06334809 | INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations(INSIDE) | recruiting | — | 400 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | recruiting | — | 5,000 | National Cancer Centre, SingaporeOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06546267 | Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)(PROST-ART) | recruiting | — | 2,500 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT01342367 | Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer | active not recruiting | N/A | 74 | University of ChicagoOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT02804815 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | active not recruiting | Phase 3 | 11,000 | University College, LondonOTHER | 2 | Jun 10, 2025 | clinicaltrials |
| NCT05936736 | 24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer(PRO-FAST) | recruiting | N/A | 70 | IRCCS San RaffaeleOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 150 | Cancer Research UKOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06215508 | Geriatric Assessment and Technology Evaluation in Prostate Cancer | recruiting | — | 120 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT01550237 | Curative Image Guided Radiotherapy for Prostate Cancer(RIC) | active not recruiting | N/A | 260 | St. Olavs HospitalOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05577689 | Novel Therapy Target in Metastatic Prostate Cancer(NTTPro) | recruiting | — | 100 | Fudan UniversityOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06815055 | State of Play of Physiotherapy in the Postoperative Management of Prostate Cancer : Prospective, Monocentric, National Survey, Aiming to Explore the Technics of Physiotherapy (PREduKiné)(PREduKiné) | not yet recruiting | — | 510 | Centre Hospitalier de RoubaixOTHER | 0 | Jun 5, 2025 | clinicaltrials |
| NCT07001709 | Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)(ENABLE) | recruiting | Phase 4 | 29 | Deventer ZiekenhuisOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT03564275 | Proton Boost in Prostate Cancer | active not recruiting | N/A | 10 | University of CincinnatiOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06355336 | Real World Prostate Cancer Registry(RWPCR) | recruiting | — | 1,000 | Cincinnati Cancer AdvisorsNETWORK | 1 | May 31, 2025 | clinicaltrials |
| NCT05805436 | Preop Laxatives in Robotic Urologic Surgery | recruiting | Phase 4 | 240 | Chad R. TracyOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06049355 | EMBRACE: Exercising Together | recruiting | Phase 2 | 400 | OHSU Knight Cancer InstituteOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT01783145 | Shared Care Follow-up After Chemotherapy for Testicular Cancer(SCFU-TC) | active not recruiting | — | 163 | University Medical Center GroningenOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT02572934 | Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)(STANDBY) | active not recruiting | — | 281 | University Medical Center GroningenOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT01221168 | Epidemiologic and Genetic Study on Familial Prostate Cancer | recruiting | — | 10,000 | Centre de Recherche sur les Pathologies ProstatiquesOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT03392181 | PET/MRI for the Staging of Newly Diagnosed Prostate Cancer | active not recruiting | Early Phase 1 | 48 | Northwestern UniversityOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT06985004 | Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire | active not recruiting | — | 288 | Pomeranian Medical University SzczecinOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT05999396 | FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer(CoRe_CC-3) | recruiting | Phase 1 | 89 | German Cancer Research CenterOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06383052 | A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC | active not recruiting | Phase 1 / Phase 2 | 30 | Norroy Bioscience Co., LTDINDUSTRY | 1 | May 21, 2025 | clinicaltrials |
| NCT05443412 | Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection | recruiting | — | 510 | Chinese University of Hong KongOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06981377 | PRostate Cancer Plasma Integrative Multi-modal Evaluation(PRIME) | recruiting | — | 800 | Santa Chiara HospitalOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06977906 | Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes | recruiting | N/A | 300 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT05592639 | VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer(VELRAD) | active not recruiting | N/A | 50 | University College, LondonOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT06974539 | TULIP ReTrain Study(TULIP ReTrain) | not yet recruiting | N/A | 212 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04848909 | Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy(PLUTO-MPC) | active not recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06972628 | Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 | recruiting | Phase 2 | 30 | Ebrahim S DelpassandOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT03874884 | 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer(LuPARP) | active not recruiting | Phase 1 | 70 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06971211 | Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC(PARTOM) | recruiting | Phase 2 | 40 | Jianbin BiOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05062707 | Early Ageing During Therapy in AYA Cancer Patients | recruiting | — | 120 | University Medical Center GroningenOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06139575 | Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer | recruiting | Phase 1 / Phase 2 | 90 | Bivision Pharmaceuticals, Inc.INDUSTRY | 1 | May 13, 2025 | clinicaltrials |
| NCT06966089 | ExosomeDx in MRI-negative Men With High PSA | not yet recruiting | N/A | 425 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT04186585 | Recommended Dose Estimation of BP-C2 | recruiting | Phase 1 | 8 | MeddocOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT04484701 | [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | active not recruiting | — | 1,574 | British Columbia Cancer AgencyOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05582876 | Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer(PROSPETMR2021) | recruiting | N/A | 366 | Medical University of BialystokOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT03344835 | Hong Kong Prostate Cancer Study Group Database | recruiting | — | 15,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03703778 | Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)(READT) | active not recruiting | — | 300 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03893929 | The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population | recruiting | — | 5,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03914391 | To Identify Potential New Urine Markers for the Screening of Prostate Cancer | recruiting | — | 10,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT05761093 | Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment | recruiting | — | 306 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jun 24, 2025source: clinicaltrials